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Abstract
A total of 54 clinical samples, including genital lesion swabs, whole blood and cerebrospinal
fluid from patients diagnosed with syphilis were collected in 2006 and in 2013 in Buenos
Aires, Argentina. Treponemal DNA was detected in 43 of the analyzed samples (79.6%)
and further analyzed using Sequencing-based molecular typing (SBMT) and Enhanced
CDC-typing (ECDCT). By SBMT, 10 different Treponema pallidum subsp. pallidum (TPA)
genotypes were found, of which six were related to the TPA SS14 strain, and four to the
TPA Nichols strain. The 23S rRNA gene was amplified in samples isolated from 42 patients,
and in six of them (14.3%), either the A2058G (four patients, 9.5%) or the A2059G (two
patients, 4.8%) mutations were found. In addition to Taiwan, Madagascar and Peru, Argen-
tina is another country where the prevalence of Nichols-like isolates (26.8%) is greater than
10%.
Introduction
Syphilis is a sexually transmitted disease caused by Treponema pallidum subsp. pallidum
(TPA). Even though syphilis is a curable disease, the incidence remains at high levels around
the world. In 2012 the World Health Organization estimated a global incidence of 5.6 million
new syphilis cases in women and men aged 15–49 years worldwide and nearly one million
new cases in the Region of the Americas [1]. In Argentina, several studies have identified pop-
ulations vulnerable to syphilis. In men who have sex with men (MSM) from Buenos Aires,
syphilis prevalence ranged from 16.9% to 20.5% [2, 3]. Similarly, high syphilis prevalence has
been found among female sex workers (22.4%) [4], and an even higher prevalence among
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The genetic characteristics of TPA have been of increasing interest over the past years as an
important tool to better understand the epidemiology and network transmission of syphilis
infections [8, 9]. Moreover, molecular characterization could be an important tool in the
future given the relatively recent emergence of macrolide resistant strains [10].
The Centers for Disease Control and Prevention (CDC, USA) recommend a typing scheme
based on the determination of the number of 60 bp-long repeats in the arp gene and on the
restriction fragment length polymorphism analyses of tprE, tprG, and tprJ genes [11]. Recently,
sequencing of a portion of the TP0548 gene was added to CDC typing (ECDCT), which in-
creased the discriminatory power of this typing scheme. ECDCT currently includes analysis of
arp gene, tprE, G and J genes, and TP0548 gene [12]. An alternative molecular typing scheme
for TPA was introduced by Flasarova´ et al. in 2006 [13], which was based on sequencing of
selected sections of genes TP0136 and TP0548 and selected coordinates in the 23S rRNA gene
to reveal macrolide resistance markers [13–15]. While ECDCT is used worldwide and many
typing studies have been published using this scheme, SBMT has until now only been used in
the Czech Republic and Belgium. One of the benefits of SBMT is that it enables the creation of
phylogenetic or network trees to trace syphilis infection.
The aim of this study was to characterize TPA isolates collected in Buenos Aires, Argentina
with both Enhanced CDC-typing (ECDCT) and Sequencing-based typing (SBMT).
Methods
Clinical samples
Clinical samples were collected from patients with syphilis diagnosed at the Hospital de Clı´ni-
cas “Jose´ de San Martı´n”, Universidad de Buenos Aires, Argentina. Between March and Octo-
ber 2013, 40 samples were collected including 33 genital lesion swabs, four cerebrospinal fluid
samples (CSF), and three whole blood samples. In addition, 14 genital lesion swabs were col-
lected between August and October 2006 and included in this study. Patients suspected of hav-
ing syphilis based on clinical findings were diagnosed with laboratory tests that included Dark
field examination of lesion material and serological tests. Serology included the Venereal Dis-
ease Research Laboratory (VDRL) test (Wiener Laboratorios, SAIC, Rosario, Argentina) and
the Fluorescent Treponemal Antibody Absorption test (FTA-Abs, Inmunofluor Biocientifica
SA, Argentina). Patients were considered to have syphilis when one of the tests (Dark field
examination and/or serology) was positive.
DNA extraction
Clinical samples (swabs, whole blood, and cerebrospinal fluids) were used for DNA isolation
using a QIAamp DNA Minikit (Qiagen, Hilden, Germany) according to the manufacturer’s
recommendations.
Detection of treponemal DNA
For the detection of treponemal DNA in clinical samples, a nested PCR amplification of the
polA and tmpC genes was performed as described previously [15]. Samples were considered
PCR-positive for treponemal DNA when PCR amplification was twice positive for at least one
treponemal locus. To test whether the samples contained PCR inhibitors, the human gene
encoding the enzyme methylenetetrahydrofolatereductase (MTHFR) was amplified using PCR
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in treponemal DNA-negative samples after the addition of human DNA as described previ-
ously [15].
Molecular typing of treponemal DNA
SBMT was performed to type all positive samples as described previously [14]. Briefly, three
loci including TP0136, TP0548, and 23S rRNA genes were amplified using the nested PCR
protocol and the amplicons obtained were sequenced. Additionally, ECDCT was applied to all
PCR-positive samples. This typing scheme included the determination of the number of 60-bp
repetitions in the arp gene, Restriction Fragment Length Polymorphism (RFLP) analysis of the
tprE, G and J genes, and sequencing of an 83-bp long fragment within the TP0548 gene (posi-
tion 130–212 of TPANIC_0548; TPA Nichols; accession no. CP004010.2) as described previ-
ously [11, 12]. A DNA sample of the reference TPA Nichols strain served as the positive
control for amplification of TPA DNA.
DNA sequencing
PCR products of the TP0136, TP0548, and 23S rRNA genes were purified using a QIAquick
PCR Purification Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
The PCR products were sequenced on an automated capillary DNA sequencing system
(GATC-Biotech AG, Constance, Germany). Sequence analyses were performed using Laser-
gene software (DNASTAR v. 7.1.0.; DNASTAR, Madison, WI). Sequences of 23S rRNA gene
amplicons were evaluated only at positions 2058 and 2059 in the 23S rRNA gene of Escherichia
coli (accession no. V00331), where A!G mutations are associated with macrolide resistance.
Phylogenetic analyses
Phylogenetic trees were generated with MEGA 6 using the bootstrapping Maximum-likeli-
hood algorithm, Tamura Nei model [16], and Network software with the Median Joining
algorithm [17]. Both Maximum-likelihood and Median Joining algorithms were used for gen-
eration of trees from concatenated sequences of TP0136, TP0548, and 23S rRNA genes. Alto-
gether, 1930 bp-long concatenated sequences corresponded to coordinates 303–1450, 110–
868, 2100–2101 of TPANIC_0136, TPANIC_0548, and TPANIC_r0002 genes (numbering is
based on the Nichols genome, CP004010.2). Concatenated sequences were analyzed for all
samples that were typed using SBMT in the Czech Republic and in Argentina since 2006.
Statistical methods
Analyses of statistical significance were performed using Fisher’s exact two-tailed test with
STATISTICA software v.12 (StatSoft, Tulsa, OK). P values lower than 0.05 were considered to
be statistically significant.
Ethics statement
This study was approved by the Ethics Committee of the Hospital de Clı´nicas “Jose´ de San
Martı´n,” Universidad de Buenos Aires and all patients provided their written informed con-
sent. The study was conducted according to the principles expressed in the Declaration of Hel-
sinki [18].
GenBank accession numbers
Unique sequences identified in this study were deposited in GenBank under following acces-
sion numbers: KY550364- KY550367.
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Results
Characteristics of patients and clinical samples
A total of 54 samples (47 genital lesion swabs, four CSF, and three whole blood samples) were
collected in 2006 and in 2013 from patients with syphilis. Out of 43 samples, where dark field
microscopy was performed, 32.6% were positive. Except of two patients that were positive
based on dark field examination with negative serology, all other patients were positive for
serological tests (96.3%). Treponemal DNA (polA and/or tmpC) was detected in 43 of the sam-
ples analyzed (79.6%) (Fig 1). External control was used to identify PCR inhibitors in all PCR-
negative samples (see Methods section). PCR inhibitors were found in four samples (three
CSF, one swab) and these samples were excluded from further analyses. Clinical characteristics
of patients with syphilis diagnosis (based on serological and dark field microscopy examina-
tion) are presented in Table 1. Briefly, most of the patients were men with a mean age of 35
years, 56% of the individuals were MSM and approximately 46% had HIV infection. Regarding
clinical status, most of the patients had primary syphilis at recruitment. No significant differ-
ences were observed between patients with positive PCR samples and those with negative PCR
(Fisher’s exact two-tailed test) (Table 1).
Sequencing-based molecular typing (SBMT)
Forty-three PCR-positive samples were analyzed using SBMT and 41 of them were typeable
(95.3%). Samples were considered typeable when at least one sequence of the typing locus
(either TP0136 or TP0548) was obtained. Samples from 35 patients were completely typed
(including the TP0136, TP0548, and 23S rRNA genes sequences), while samples from six
patients were only partially typed (Fig 1).
Altogether, 10 different TPA genotypes were found among the fully typed and partially
typed samples; six were related to the sequence from the TPA strain SS14 (SSS, SU10S, SU11S,
SSR9, SU2R8, SSR8), and four were related to the sequence from the TPA strain Nichols
(U3U6S, U3U6R8, U3U12S, U5XS). All identified genotypes found in this study are shown in
Table 2.
Fig 1. Flow chart of 54 patients included in the study.
doi:10.1371/journal.pone.0172905.g001
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The most prevalent genotype (SSS) was found in 15 (36.6%) out of 41 typed isolates and
was sequentially identical to TPA SS14. However, unlike strain SS14, isolates with the SSS
genotype were sensitive to macrolides. Other prevalent genotypes included U3U6S (14.6%)
which was related to the TPA Nichols, and the SU10S genotype (12.2%) which was related to
the TPA SS14. In addition, genotypes SU2R8, SU11S, and SSR9 were detected in two indepen-
dent clinical samples while other genotypes were detected in only one sample. According to
either TP0136 and/or TP0548 analyses, treponemes in 30 clinical samples (73.2%) belonged to
the SS14-like group and 11 (26.8%) belonged to the Nichols-like group. Moreover, five new
genotypes (SU10S, SU11S, U3U12S, U3U6S, and U5XS) were detected and characterized in
this study. Unique sequence U5 found at the TP0136 locus differed in a 96 bp-long deletion
and one substitution compared to TPA Nichols. Unique sequences U10 and U11 found at
the TP0548 locus each differed in one nucleotide position compared to TPA SS14. Unique
sequence U12 found at the TP0548 locus had 3 substitutions compared to TPA Nichols. Align-
ment of TP0136 and TP0548 unique sequences are shown in Fig 2 and Fig 3.
Enhanced CDC-typing (ECDCT)
ECDCT was applied to 43 PCR-positive samples and 40 were typeable: 23 were fully typed and
17 partially typed (Fig 1). Samples were considered typeable when at least one PCR amplicon
(containing either arp, tprEGJ, or TP0548) was obtained. Altogether, 10 different genotypes
were detected among the fully and partially typed samples (14d/d, 14d/f, 7d/f, 15d/f, 14d/g,
11d/f, 16d/e, Xb/f, 16p/X, Xk/f). Genotypes 14d/d and 14d/f were the most prevalent (15%
each), followed by 7d/f (10%). Other genotypes, were detected in two (5% each) or in one sam-
ple (2.5% each) (Table 3.). Using this methodology, no new genotypes were detected.
Prevalence of macrolide resistance-causing mutations in syphilis-
causing treponemes
The 23S rRNA gene locus was amplified in 42 samples, and in six of them (14.3%), either the
A2058G (four patients, 9.5%) or the A2059G (two patients, 4.8%) mutation was found. No
Table 1. Characteristics of 50 patients enrolled in this study during 2006 and 2013 in Buenos Aires, Argentina.
Patient’s characteristics All patients (n = 50) PCR-positive patients (n = 43) PCR-negative patients (n = 7)
Mean age in years (range)a 35.6 (17–66) 33.4 (17–67) 37.7 (19–66)
No. (%)
Males 48 (96) 41 (95.4) 7 (100)
MSMb 27 (56.3) 23 (56) 4 (57.1)
HIV positivec 12 (46.2) 11 (47.8) 1 (33.3)
Primary syphilis 32 (64) 28 (65.1) 4 (57.1)
Secondary syphilis 10 (20) 10 (23.3)
Congenital syphilis 1 (2) 1 (2.3)
Undetermined stage 7 (14) 4 (9.3) 3 (42.9)
Genital, anal, oral swab 43 (86) 38 (88.4) 5 (71)
Condylomata lata swab 3 (6) 3 (7) 0
CSF 1 (2) 1 (2.3) 0
Whole blood 3 (6) 1 (2.3) 2 (29)
aage information of 5 patients was not available.
bMSM—Men who have sex with men; all investigated male patients declared their sexual orientation.
cHIV status was known only in 26 patients (52%).
doi:10.1371/journal.pone.0172905.t001
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Table 2. Characteristics of detected genotypes using SBMT on 41 samples from syphilis PCR-positive patients from Buenos Aires, Argentina.
Genotypea Typing TP0136 TP0548 23S rRNA gene Strain similarity No. of isolates (%)
SSS Complete Identical to SS14 Identical to SS14 Sensitive SS14-like 15 (36.6)
U3U6Sb Complete Unique 3 Unique 6 Sensitive Nichols-like 6 (14.6)
SU10Sb Complete Identical to SS14 Unique 10 Sensitive SS14-like 5 (12.2)
SU11Sb Complete Identical to SS14 Unique 11 Sensitive SS14-like 2 (4.9)
SSR9 Complete Identical to SS14 Identical to SS14 A2059G SS14-like 2 (4.9)
SU2R8 Complete Identical to SS14 Unique 2 A2058G SS14-like 2 (4.9)
U3U6R8 Complete Unique 3 Unique 6 A2058G Nichols-like 1 (2.4)
U3U12Sb Complete Unique 3 Unique 12 Sensitive Nichols-like 1 (2.4)
SSR8 Complete Identical to SS14 Identical to SS14 A2058G SS14-like 1 (2.4)
XU6Sb Partial NAc Unique 6 Sensitive Nichols-like 1 (2.4)
XU10Sb Partial NA Unique 10 Sensitive SS14-like 1 (2.4)
XSS Partial NA Identical to SS14 Sensitive SS14-like 1 (2.4)
U3XS Partial Unique 3 NA Sensitive Nichols-like 1 (2.4)
SXS Partial Identical to SS14 NA Sensitive SS14-like 1 (2.4)
U5XSb Partial Unique 5 NA Sensitive Nichols-like 1 (2.4)
agenotypes were denoted using SBMT by a tree-letter code [14]. Briefly, the first letter stands for the TP0136 sequence (S, identical to SS14; U, unique
sequence compared to SS14 strain; X, not determined), the second letter stands for the TP0548 sequence (S, identical to SS14; U, unique sequence
compared to SS14 strain; X, not determined), and the third letter stands for sensitivity/resistance to macrolide antibiotics (S, sensitive; R8, A2058G,
resistant; R9, A2059G, resistant).
bnew genotypes detected in this study (shown in bold).
cNA, not available.
doi:10.1371/journal.pone.0172905.t002
Fig 2. Alignment of TP0136 unique sequences identified to date [this study, 14, 15, 19]. Only positions
containing nucleotide variants are shown. A. Nucleotide differences between reference strain TPA SS14 and
TPA Nichols in the region characterized using SBMT (at coordinates 264–1469 according to the TPANIC_0136;
CP004010.2). Coordinates shown above correspond to TPASS_0136 (TPA SS14; CP004011.1) and
coordinates shown below correspond to TPANIC_0136 (TPA Nichols; CP004010.2). B. Nucleotide differences
in SS14-like unique sequences. Coordinates correspond to TPASS_0136 (TPA SS14; CP004011.1). ND, was
not determined due to the limited amount of sample DNA. The white lines between coordinates indicate the non-
continuous nucleotide positions. C. Nucleotide differences in Nichols-like unique sequences. Coordinates
correspond to TPANIC_0136 (TPA Nichols; CP004010.2). The new unique sequence identified in this study is
shown in bold. The white lines between coordinates indicate the non-continuous nucleotide positions.
doi:10.1371/journal.pone.0172905.g002
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strains harbored both A2058G and A2059G mutations. The A2058G mutation was present in
samples isolated in 2006 and 2013, while the A2059G mutation was detected only in samples
from 2013. Macrolide resistance was detected in both SS14-like (5/30) and Nichols-like (1/11)
clinical isolates without significant differences (16.7% and 9.1%, respectively).
Statistical analysis
We used the Fisher’s exact two-tailed test to examine associations between genotypes, TP0136/
TP0548 alleles, Nichols-like/SS14-like groups, the arp locus or tprEGJ loci and macrolide sensi-
tivity/resistance, MSM status, patient’s age, syphilis stage or time of isolation. No statistically
significant associations were found (data not shown).
Discussion
This study explored, for the first time, the characteristics of Treponema pallidum subsp. palli-
dum (TPA) circulating in Buenos Aires, Argentina. Besides the report on six TPA isolates
Fig 3. Alignment of all TP0548 unique sequences identified to date [this study, 14, 15, 19]. Only
positions containing nucleotide variants are shown. A. Nucleotide differences between reference strain TPA
SS14 and TPA Nichols in the region characterized using SBMT (at coordinates 16–1080 of TPANIC_0548;
CP004010.2). Coordinates shown above correspond to TPASS_0548 (TPA SS14; CP004011.1) and
coordinates shown below correspond to TPANIC_0548 (TPA Nichols; CP004010.2). B. Nucleotide differences
in SS14-like unique sequences. Coordinates correspond to TPASS_0548 (TPA SS14; CP004011.1). New
unique sequences identified in this study are shown in bold. The white lines between coordinates indicate the
non-continuous nucleotide positions. Highlighted coordinates shown in white (154, 155, 158) correspond to
regions determined by ECDCT. C. Nucleotide differences in Nichols-like unique sequences. Coordinates
correspond to TPANIC_0548 (TPA Nichols; CP004010.2). New unique sequence identified in this study is
shown in bold. The white lines between coordinates indicate the non-continuous nucleotide positions.
Highlighted coordinates shown in white (170, 208) correspond to regions determined by ECDCT.
doi:10.1371/journal.pone.0172905.g003
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from Colombia [20] and 14 TPA isolates from Peru [21], this is one of the first attempts to
study TPA diversity in South America using a larger sample set.
In our study, two different typing schemes were applied to TPA clinical isolates. Among
samples from 54 patients with positive syphilis serology and/or dark field microscopy, the
majority were characterized using ECDCT [11, 12] and SBMT [13, 14]. Altogether, 10 different
treponemal genotypes were identified by both typing systems. SBMT revealed five new geno-
types that were denoted using three-letter codes as described previously (SU10S, SU11S,
U3U12S, U3U6S, and U5XS) [14] (Fig 4A). In contrast, no new subtypes were identified using
ECDCT. This discrepancy likely reflects differences in the global number of clinical isolates
characterized using the different methods; while altogether SBMT was carried out to type 175
samples [13–15, 19; this study], ECDCT was used to type almost two thousand clinical isolates
[12, 21–32]. Another hypothesis is related to the fact that the typing efficiency was lower by
ECDCT (53.5% of clinical isolates were fully typed) compared to SBMT (83.7%). Partial molec-
ular typing obtained by ECDCT was mostly due to the low success rate of the arp gene PCR
assay (failed in 15 out of 43 samples), something which has also been observed in other studies
[33–35].
In this study, the most prevalent genotypes were 14d/d and 14d/f (15% each). Subtype 14d/f
was also a predominant genotype in other countries including China [12, 23, 25, 27, 32], Peru
[21], Russia [29], and the USA [12, 24]. On the other hand, subtype 14d/d was never observed
to be a predominant genotype in any country where ECDCT was used [12, 21–32]. The geno-
types previously found in Colombia and Peru [20, 21] were also identified in this study (except
for the 13d and 22a, which were present in Colombia and 13X/f and XX/a genotypes, which
were present in Peru). The most prevalent genotype detected using SBMT was SSS (36.6%)
Table 3. ECDCT genotypes detected in 40 samples from syphilis PCR-positive patients from Buenos
Aires, Argentina.
Subtypea Typing No. of isolates (Frequency, %)
14 d/d Complete 6 (15.0)
14 d/f Complete 6 (15.0)
7 d/f Complete 4 (10.0)
15 d/f Complete 2 (5.0)
14 d/g Complete 2 (5.0)
11 d/f Complete 2 (5.0)
16 d/e Complete 1 (2.5)
X d/f Partial 6 (15.0)
X b/f Partial 2 (5.0)
X d/d Partial 2 (5.0)
16 p/Xb Partial 1 (2.5)
14 X/f Partial 1 (2.5)
X d/X Partial 1 (2.5)
X k/f Partial 1 (2.5)
X X/d Partial 1 (2.5)
X X/e Partial 1 (2.5)
X X/f Partial 1 (2.5)
asubtypes were denoted using ECDCT [11, 12]. Briefly, the number stands for number of repetitions in the
arp gene, the first letter stands for type revealed from RFLP analysis of tprE, G and J genes and the last
letter stands for the 83-bp long sequence of TP0548.
bX, undetermined.
doi:10.1371/journal.pone.0172905.t003
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followed by U3U6S (14.6%), and the newly described SU9S (12.2%). This genotype distribu-
tion is different from that reported by Grillova´ et al. [15] in clinical samples from the Czech
Republic, where SU2R8 was the most prevalent type (37.5%) followed by SSS (22.5%) and
SU5R8 (15%). Several studies have shown that predominant treponemal strains in a particular
population can change over time [12, 14, 15]. It has been described previously [14] that there is
no relationship between genotypes identified using SBMT and ECDCT. In this study,
Fig 4. Genotypes identified using SBMT to date in the Czech Republic and in Argentina [this study, 14, 15]
and their phylogenetic and network analyses. A. Genotypes identified exclusively in the Czech Republic (dark
grey background), in Argentina (light grey background) and in both locations. Both fully and partially typed genotypes
are shown. B. The phylogenetic tree of concatenated sequences of TP0136, TP0548, and 23S rRNA. Partially typed
genotypes (XU8R9, XU3R8, XU4R9, and U5XS) were excluded. The U2SS genotype is also not shown due to the
short sequence obtained from the TP0136 gene. Genotypes identified in this study are shown in bold. The bar scale
represents 0.005 substitutions per target site. The numbers at each node correspond to bootstrap values. C. The
network tree of concatenated sequences of TP0136, TP0548, and 23S rRNA genes. Partially typed genotypes
(XU8R9, XU3R8, XU4R9 and U5XS) were excluded. The U2SS genotype is also not shown due to the short sequence
obtained from the TP0136 gene. Every circle represents a different genotype. The small numbers represent the
phylogenetic distances between genotypes. The black circle represents an unknown ancestor. Genotypes identified in
the Czech Republic and in Argentina are shown in dark and light grey, respectively.
doi:10.1371/journal.pone.0172905.g004
Table 4. Comparison of fully typed clinical isolates using ECDCT and SBMT. Only samples with fully-typed genotypes in both typing schemes are
shown.
Genotypes/subtypes 7d/f 11d/f 14d/d 14d/f 16d/e 15d/f 14d/g
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treponemes with SBMT genotype SSS were further divided using ECDCT into subtypes 7d/f,
11d/f, and 14d/f. On the other hand, subtype 14d/f was further divided using SBMT into geno-
types SSS, SSR8, and SU9S. All other SBMT genotypes were represented by a single ECDCT
genotype and vice versa (Table 4.). These data suggest that the arp and tprEGJ loci are indepen-
dent of TP0136 and TP0548. Moreover, higher variability at the arp and tpr loci have been
found among different clinical isolates obtained from the same patient [36].
Based on whole and partial genome sequence analyses of laboratory TPA strains and clini-
cal isolates, two genetically distinct groups were found [37–39]. Syphilis-causing strains were
either genetically related to the reference strain SS14 (SS14-like strains) or to the Nichols refer-
ence strain (Nichols-like strains) (Fig 4B). Both, the 83bp region of TP0548 analyzed using
ECDCT and the 1065 bp region of TP0548 analyzed by SBMT can be used to classify clinical
isolates as either SS14-like or Nichols-like. So far, most of the sequentially characterized clini-
cal isolates (n = 1746) belong to the SS14-like group (n = 1635; 93.6%) and only 6.4% belong to
the Nichols-like group [12, 14, 15, 19, 21–32]. However, the geographic distribution of both
groups differs. While the prevalence of clinical isolates containing Nichols-like treponemal
DNA was 0% in the UK and Russia [22, 29] and very low (under 10%) in Australia, China,
Czech Republic, Denmark, France, Ireland, and USA [12, 14, 15, 23–26, 30–32], a higher prev-
alence of Nichols-like treponemes was detected in Peru (21.4%) [21], Taiwan (20.2%) [28],
and Madagascar, where, surprisingly, 100% of the typed clinical samples were Nichols-like
[12]. In addition to Peru, Taiwan, and Madagascar, data from this study showed a high preva-
lence of Nichols-like isolates in Argentina (26.8%; based on TP0136 and/or TP0548). Since
four different genotypes were found among 11 clinical isolates belonging to the Nichols-like
TPA group in Argentina, the variability within Nichols-like clinical isolates appears to be simi-
lar to or greater than that found in the SS14-like group, where six different genotypes were
found among 30 SS14-like clinical samples.
When the results obtained in this study were compared to previous SBMT studies per-
formed in the Czech Republic [13–15], five distinct genotypes were present in both locations
while nine genotypes were found only in the Czech Republic and five only in Argentina (Fig
4A and 4C). These results support the findings of other authors [12, 24, 30] i.e., unique sub-
types exist in a particular geographic area and common subtypes exist globally. The MJ net-
work analyses of genotypes from the Czech Republic and Argentina revealed that all the
genotypes identified in the SS14-like group showed a star-like topology (Fig 4C). The central
genotype is the most prevalent one (SSS), which is probably the origin of the rest of SS14-like
genotypes found in clinical samples. The exceptions are SU2S, SU2R8 and SU5R8 genotypes,
which arose probably independently from the SSS genotype from an unknown ancestor (Fig
4C). Interestingly, when the genotypes from a branch with a star-like topology were compared
to genotypes with a linear topology, we found a statistically significant association (p = 0.039;
Fisher’s exact two-tailed test) between SU2S, SU2R8, and SU5R8 genotypes and MSM patients,
suggesting that these genotypes spread mainly among MSM patients.
In Argentina, we found macrolide resistance-associated mutations (either A2058G or
A2059G) in only 14.3% of the samples analyzed. Although in clinical samples isolated from
2006 macrolide resistance-associated mutations were found only among Nichols-like geno-
types; in samples obtained in 2013 macrolide resistance was found in both genetically distinct
groups. There are several other geographical areas where the prevalence of macrolide resis-
tance is still quite low and these areas include Canada (12.1%) [40–41], Russia (2.4%) [29],
South Africa (1%) [42], Madagascar (0.7%) [24, 43], Taiwan (0.7%) [28], and Peru, where no
macrolide-resistant mutations have been found among the 10 samples analyzed to date [21].
However, a high prevalence of macrolide resistance (61%–100%) has been reported around
the world by different studies carried out in Australia, Cuba, Czech Republic, China, Ireland,
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UK, and the USA [14, 15, 22, 24, 32, 44–54]. Moreover, several studies have described an
increasing trend in macrolide resistance in TPA clinical isolates [reviewed in 55]. In addition
to the 10 genotypes, which were typed in at least two independent chromosomal TPA loci and
showing identical typing results with different macrolide resistance genotypes (nine related to
the SS14 strain and one to the Nichols strain) [30, 55], we also found that the U3U6 genotype
(belonging to the Nichols-like group) had two variants in the 23S rRNA gene including a wild-
type and A2058G genotype. This finding supports the scenario in which macrolide resistance
emerged independently several times in both Nichols and SS14-like treponemes.
In conclusion, this is one of the first extensive reports on TPA molecular typing in South
America. In it we analyzed clinical samples using two typing methods (ECDCT and SBMT).
SBMT was used to detect five new genotypes as well as new genotypes within the Nichols-like
group of TPA. Macrolide resistant TPA isolates were detected in South America at a relatively
low frequency compared to studies from other geographical areas.
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